Individualized Intraperitoneal and System Chemotherapy Versus System Chemotherapy as First-line Chemotherapy for AGC
- Status
- UNKNOWN
- Phase
- PHASE3
Clinical Trials Related to Oxaliplatin
Related studies linked through entity extraction aliases.
Standard of Care Alone or in Combination With Ad-CEA Vaccine and Avelumab in People With Previously Untreated Metastatic Colorectal Cancer QUILT-2.004
- Status
- TERMINATED
- Phase
- PHASE2
mFOLFOX Versus mFOLFIRI Versus FOLFPTX as First-line Treatment in AGC or EGJA
- Status
- UNKNOWN
- Phase
- NA
mFOLFOX6 vs. mFOLFOX6 + Aflibercept as Neoadjuvant Treatment in MRI-defined T3-rectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Oxaliplatin and Capecitabine in Unresectable Metastatic Hepatocellular Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Paediatric Hepatic International Tumour Trial
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
PREACT Study: Locally Advanced Gastric Cancer, Chemoradiotherapy vs. Chemotherapy Followed by D2 Surgery and Adjuvant Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE3
Study of IMM 101 in Combination With Standard of Care in Patients With Metastatic or Unresectable Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
The Study of Conversion Surgery for Apatinib in Combination With SOX for Patients With Unresectable Gastric Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Study of Adjuvant ONO-4538 With Resected Gastric Cancer
- Status
- COMPLETED
- Phase
- PHASE3
PHASE III RANDOMISED TRIAL to EVALUATE FOLFOX with or WITHOUT DOCETAXEL (TFOX) AS 1st LINE CHEMOTHERAPY for LOCALLY ADVANCED or METASTATIC OESOPHAGO-GASTRIC CARCINOMA
- Status
- COMPLETED
- Phase
- PHASE3
To Observe the Efficacy and Safety by Comparing Chemotherapy(Docetaxel, Oxaliplatin Plus S1 ) Followed With Radical Resection Versus Chemotherapy Alone in Advanced Gastric Cancer With Single Non-curable Factor.
- Status
- UNKNOWN
- Phase
- N/A
Induction Therapy With Panitumumab + mFOLFOX-6 in Rectal Cancer and Quadruple Wild-type Mutation Before Surgery
- Status
- COMPLETED
- Phase
- PHASE2
Testing the Addition of Atezolizumab to Combination Chemotherapy or Atezolizumab Alone for Metastatic Colon or Rectal Cancer, the COMMIT Study
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Long Term Effect of Oxaliplatin Treatment in Cancer Survivors
- Status
- COMPLETED
- Phase
- N/A
Phase II Trial of Pembrolizumab With Trastuzumab and Chemotherapy in Advanced HER2 Positive Esophagogastric (EG) Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Trial of Magrolimab (Hu5F9-G4) in Combination With Rituximab or Rituximab + Chemotherapy in Participants With Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Avelumab In Combination Regimens That Include An Immune Agonist, Epigenetic Modulator, CD20 Antagonist and/or Conventional Chemotherapy in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (R/R DLBCL)
- Status
- TERMINATED
- Phase
- PHASE3
Neoadjuvant Chemotherapy With SEEOX Regimen for Borrmann Type 4 Gastric Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Multicentric Randomised Trial for Resectable Gastric Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2